金河生物：投资1000万元设立全资子公司

Core Insights - The company Jinhe Biotechnology reported its revenue composition for the first half of 2025, with veterinary chemical drugs accounting for 61.83% of total revenue, followed by agricultural product processing at 19.76%, veterinary biological products at 11.12%, environmental protection business at 4.97%, and others at 2.15% [1] - On August 19, 2025, Jinhe Biotechnology announced the establishment of a wholly-owned subsidiary, Jinhe Aichongyi (Shanghai) Biotechnology Co., Ltd., with an investment of 10 million yuan [3] Revenue Composition - Veterinary chemical drugs: 61.83% [1] - Agricultural product processing: 19.76% [1] - Veterinary biological products: 11.12% [1] - Environmental protection business: 4.97% [1] - Other: 2.15% [1] Corporate Actions - Approval of the establishment of a wholly-owned subsidiary [3] - Investment amount for the new subsidiary: 10 million yuan [3]